Efficacy and safety of alpelisib plus olaparib versus chemotherapy among patients with platinum-resistant or refractory high-grade serous ovarian cancer without BRCA mutation: Primary analysis of the EPIK-O trial
| Image |  |
|---|---|
| Description | scientific article published in November 2024 |
| Author/s |
author: Nicoletta Colombo Domenica Lorusso Els Van Nieuwenhuysen Rachel N. Grisham Christian Marth |
| Publication date | November 2024 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |